- Home
- MHK vs ASND Comparison
MHK vs ASND Comparison
Compare MHK & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MHK | ASND |
|---|---|---|
| Founded | 1988 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.6B | 13.6B |
| IPO Year | 1995 | 2014 |
Fundamental Metrics
Financial Performance| Metric | MHK | ASND |
|---|---|---|
| Price | $102.23 | $216.82 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 16 |
| Target Price | $137.78 | ★ $279.50 |
| AVG Volume (30 Days) | ★ 948.2K | 559.4K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 5.93 | N/A |
| Revenue | N/A | ★ N/A |
| Revenue This Year | $3.53 | $98.57 |
| Revenue Next Year | $3.10 | $43.22 |
| P/E Ratio | $17.19 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $95.16 | $124.06 |
| 52 Week High | $143.13 | $248.60 |
Technical Indicators
Market Signals| Indicator | MHK | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 35.86 | 37.58 |
| Support Level | $97.42 | $189.53 |
| Resistance Level | $116.52 | $222.47 |
| Average True Range (ATR) | 3.86 | 6.91 |
| MACD | -0.48 | -2.50 |
| Stochastic Oscillator | 34.09 | 10.16 |
Price Performance
Historical ComparisonAbout MHK Mohawk Industries Inc.
Mohawk Industries Inc manufactures a wide range of flooring products, including carpets, rugs, ceramic tile, laminate, wood, luxury vinyl tile, and vinyl flooring. Its operating segments include Global Ceramic, Flooring North America, and Flooring Rest of the World. The company generates maximum revenue from the Global Ceramic segment. Global Ceramic designs, manufactures, sources, distributes and markets a broad line of ceramic, porcelain and natural stone tile products used for floor and wall applications in residential and commercial channels for both remodeling and new construction. Geographically, it derives a majority of its revenue from the United States, while it also operates in Latin America, Europe and Others.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.